drugset / Trial / NCT01234194
Composite Variability Index and Propofol Remifentanil Anesthesia
RandomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of the study is to determine if the new Composite Variability Index (CVI) is capable of detecting changing effect compartment concentrations of remifentanil. In addition, it is planed to detect if the change in CVI in response to a standardized painful stimulus is dose-dependent.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Remifentanil | Small molecule | — | — |
Indications
No indication recorded.